BIOMEDICAL RESEARCH NEWS, AND ARTICLES
Promed Bioscience enters into partnership with US-based business accelerator, Kinisis Ventures.
18 June 2020
Kinisis Ventures Limited (KV), a business accelerator focused exclusively on identifying and preparing Cyprus-based companies to enter the United States market, has signed a partnership agreement with Promed Bioscience to help develop a USA go-to-market strategy for Promed’s B2B and B2C collagen products aimed at the research, skincare and medical markets.